Dedicated to the innovative formulation, development & delivery of safe & effective vaccines that expand & enhance vaccine protection in both established & emerging markets. VBI's innovative approach to vaccine development & growing pipeline of vaccine programs address significant market opportunities & are designed to answer critical unmet medical needs. Through a recent strategic acquisition, VBI has expanded its pipeline of thermostable vaccine programs & is also developing its own VLP-based vaccines. (BIOTECanada)